Skip to main content

Xiaofei Wang

Professor of Biostatistics & Bioinformatics
Biostatistics & Bioinformatics, Division of Biostatistics
Duke Box 2721, Durham, NC 27710
2424 Erwin Road Suite 1102, 11080 Hock Plaza, Duke Box 272, Durham, NC 27705

Overview


Survival Analysis
Causal Inference
Design and Analysis of Clinical Trials
Methods for Diagnostic and Predictive Medicine
Analysis of Data from Multiple Sources

Current Appointments & Affiliations


Professor of Biostatistics & Bioinformatics · 2021 - Present Biostatistics & Bioinformatics, Division of Biostatistics, Biostatistics & Bioinformatics
Member of the Duke Cancer Institute · 2015 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


A Powerful and Self-Adaptive Weighted Logrank Test.

Journal Article Stat Med · February 2026 In a weighted logrank test, such as the Harrington-Fleming test and the Tarone-Ware test, predetermined weights are used to emphasize early, middle, or late differences in survival distributions to maximize the test's power. The optimal weight function und ... Full text Link to item Cite

Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005.

Journal Article J Clin Oncol · January 13, 2026 PURPOSE: NRG Oncology/Alliance LU005 (ClinicalTrials.gov identifier: NCT03811002) tested the addition of atezolizumab to concurrent chemoradiation (CRT) in this open-label, phase III international trial. METHODS: Patients with limited-stage small cell lung ... Full text Link to item Cite

Statistical inference for heterogeneous treatment effect with right-censored data from synthesizing randomized clinical trials and real-world data.

Journal Article Biometrics · October 8, 2025 The heterogeneous treatment effect plays a crucial role in precision medicine. There is evidence that real-world data, even subject to biases, can be employed as supplementary evidence for randomized clinical trials to improve the statistical efficiency of ... Full text Link to item Cite
View All Publications

Recent Grants


AFT-61 Stats

ResearchPrincipal Investigator · Awarded by Alliance Foundation Trials, LLC · 2025 - 2030

AFT-57 Trials (5d)

ResearchPrincipal Investigator · Awarded by Alliance Foundation Trials, LLC · 2023 - 2028

Methods to improve efficiency and robustness of clinical trials using information from real-world data with hidden bias

ResearchPrincipal Investigator · Awarded by Food and Drug Administration · 2023 - 2026

View All Grants

Education, Training & Certifications


University of North Carolina, Chapel Hill · 2003 Ph.D.